Brief: Agilon Health Q3 Revenue USD 1,440 Million Vs. IBES Estimate USD 1,427 Million
04/11/2025 21:05
Nov 04 (Reuters) - Agilon Health Q3 adjusted EBITDA USD -91 million vs. IBES estimate USD -50.3 million. Q3 net income USD -110 million vs. IBES estimate USD -70.9 million
Recent news on Agilon Health
See all newsU.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics